An AI tool analyzing CCTA images can predict future cardiovascular events and death in patients with suspected stable coronary artery disease.
Key Details
- 1The FISH&CHIPS study involved 7,836 patients who underwent AI-derived FFR-CT analysis from an initial 90,553 receiving CCTA.
- 2Lower FFR-CT values correlated with significantly increased rates of MI, cardiovascular death, and all-cause mortality independent of traditional risk factors.
- 3Patients with severely reduced FFR-CT had a four-fold risk of heart attack and triple risk of death versus those with normal values.
- 4The FFR-CT AI analysis (by HeartFlow) provided additive prognostic value over classical cardiovascular risk scores.
- 5This is the first large-scale evidence of FFR-CT's independent prognostic power in stable CAD.
- 6Study funded by UK MRC; HeartFlow provided analysis but did not fund or direct the study.
Why It Matters

Source
EurekAlert
Related News

USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.

AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.

AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.